Filing Details
- Accession Number:
- 0001209191-23-041337
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-05 19:35:52
- Reporting Period:
- 2023-07-03
- Accepted Time:
- 2023-07-05 19:35:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780069 | Pamela Vig | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Head Of Research & Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-07-03 | 1,425 | $25.65 | 30,786 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 75,000 | Indirect | By The Vig-Ancock Family Trust |
Footnotes
- Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.